Root Canal Obturation With a Ready-to-use Root Canal Sealer (PA1704) Versus BioRoot™ RCS: a Randomized Controlled Trial (OPTIFILL)
Evaluation of the Efficacy Rate of Endodontic Treatment at 2 Years After Root Canal Filling With a Ready-to-use Root Canal Sealer PA1704 Versus BioRoot™ RCS: a Randomized Controlled Trial
Sponsor: Septodont
Listed as NCT04757753, this NA trial focuses on Root Canal Obturation and remains ongoing. Sponsored by Septodont, it has been updated 11 times since 2020, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
11 versions recorded-
Sep 2025 — Present [monthly]
Active Not Recruiting NA
-
Jul 2025 — Sep 2025 [monthly]
Active Not Recruiting NA
-
Nov 2024 — Jul 2025 [monthly]
Active Not Recruiting NA
-
Sep 2024 — Nov 2024 [monthly]
Active Not Recruiting NA
-
Jul 2024 — Sep 2024 [monthly]
Active Not Recruiting NA
▶ Show 6 earlier versions
-
Dec 2023 — Jul 2024 [monthly]
Active Not Recruiting NA
-
May 2023 — Dec 2023 [monthly]
Active Not Recruiting NA
-
Sep 2022 — May 2023 [monthly]
Active Not Recruiting NA
-
Oct 2021 — Sep 2022 [monthly]
Active Not Recruiting NA
Status: Recruiting → Active Not Recruiting
-
Apr 2021 — Oct 2021 [monthly]
Recruiting NA
-
Mar 2021 — Apr 2021 [monthly]
Recruiting NA
First recorded
Nov 2020
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Septodont
- Slb Pharma
For direct contact, visit the study record on ClinicalTrials.gov .